MedEdge Unveils ePTFE Platform for Medical Implantable Applications

 The company leverages proprietary manufacturing methods and materials expertise to fabricate devices for cardiovascular and other surgical procedures.

A developer of advanced medical materials and device technologies based in Suzhou, China, has announced the official launch of a medical-grade expanded polytetrafluoroethylene (ePTFE) product line and comprehensive custom contract development and manufacturing services via its new digital platform.


#MedEdgeInnovations (MEI) leverages proprietary manufacturing processes and materials science expertise to deliver premium #ePTFE components, including membranes and tubing for cardiovascular, peripheral vascular, general surgery, and other medical applications.


MEI was founded in 2021 and has 5,400 square meters of R&D, manufacturing, and administrative space in Suzhou. The company also runs an R&D center in Shanghai and a technology innovation center in Irvine, CA. In May of last year, it began construction of the second phase of its Suzhou plant, which will be primarily used for the production of medical implantable grade ePTFE tubing and membranes, according to reporting from G-MedTech.


Quality systems are certified to ISO 13485 and the company says it strictly adheres to GMP protocols to ensure compliance with international regulatory standards.


source: MedEdge/plastics Today

Comments

Popular posts from this blog

ENVALIOR ANNOUNCES NEW PPS COMPOUNDING FACILITY IN EUROPE

Today's KNOWLEDGE Share : What Is Going Wrong in UK Plastics Recycling?

Today's KNOWLEDGE Share : Robotic 3D printing can compete with traditional boatbuilding